当前位置: 首页 > 期刊 > 《中国社区医师》 > 2018年第7期
编号:13314473
CD47在肿瘤的表达与放疗增敏中作用(2)
http://www.100md.com 2018年2月19日 《中国社区医师》 2018年第7期
     [4]

    Bauer PM,Bauer EM,Rogers NM,et al.Acti- vated CD47 promotes pulmonary arterial hy- pertension through targeting eaveolin-l[J].Car-diovase Res,2012,93(4):682-693.

    [5] Odibvre MH, Bony V, Benkerrou M, et al. Modulation of Erythroid adhesion receptor expression by hydmxyureain children with sickle cell disease[J].Haematologica,2008,93(4):502-510.

    [6] SotoPantoja DR, Miller TW, Pendrak ML,eta1.CD47 deficiency confers cell and tissue radioprotection by activation of autophagy[J]. Autophagy,2012,8(11):1628-1642.

    [7]

    SotoPantoja DR,Ridnour IA,Wink DA,et al. Blockade of CD47increases survival of mice exposed to lethal total body irradiation[J],Sci Rep,2013,(3):1038.

    [8] Willingh SB, Volkmer JP, Genttes AJ,et al. The CD47-signal regulatory protein al- pha(SIRPa)interaction is a therapeutic target for human solid tumors[J].Proc Nail Acad Sei USA,2012,109(17):6662.

    [9] Huang YT,Ma Y,Cao P,et al.Targeting CD47: the achievements and concerns of current studies on cancer immunotherapy[J].J Tho-rac Dis,2017,9(2):E168-E174., 百拇医药(武霞 朱振凤 刘学键)
上一页1 2